274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial

12:40pm - 12:50pm ET

Presenter(s)

Hong Ge, MD - The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou,